Answers are grounded in this paper and cite their sources.
Background Diabetic retinopathy (DR) is recognized as one of the microvascular complications of diabetes mellitus. The increased susceptibility of the retina to oxidative stress is influenced by various factors, including glucose oxidation, which triggers lipid peroxidation. Alterations in iron homeostasis and lipid peroxidation pathways promote the expression of ferroptosis-related genes, including glutathione peroxidase 4 (GPX4). This study aimed to identify a key regulatory microRNA involved in the ferroptosis-related pathway in DR, with a focus on its potential as a diagnostic biomarker. Methods Forty-five adult participants were classified into three groups: diabetic patients without retinopathy, diabetic patients with retinopathy, and healthy controls. Ten paired blood and vitreous samples were collected. In silico analysis was performed to identify ferroptosis-related molecular pathways in DR. The expression of miRNA-188-3p was analyzed using quantitative real-time PCR (qRT-PCR). Additionally, GPX4, the GSH/GSSG ratio, ferrous ion levels, and malondialdehyde (MDA) were measured in serum and vitreous samples. Results Circulating miRNA-188-3p was significantly upregulated in patients with DR compared with the other groups, achieving 95% sensitivity and 93.3% specificity. GPX4 expression was significantly and negatively correlated with age, glycemic markers, MDA, and ferrous ions across all study groups. Conclusion miRNA-188-3p may serve as a potential blood biomarker for distinguishing diabetes without retinopathy from proliferative diabetic retinopathy. However, further research is needed to confirm its impact on ferroptosis-related pathways involving GPX4.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: